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By using isoelectric focusing spectra or idiotypy as markers,  it has been shown that 
clones of B cells producing identifiable antibody molecules can be adoptively transferred 
to syngeneic animals (1-5); cells can be obtained from ascitic fluids (5) as well as spleen. 
The work of Bangasser  et al.  suggested that,  under certain circumstances,  the domi- 
nance  of the  B-cell clones  transferred  could  prevent  the  appearance  of anti-hapten 
antibodies with the same specificity, but of a  different idiotype, that would otherwise 
have appeared upon subsequent immunization (6).  The experiments were based on the 
observation that  all A/J  mice  produced  antibodies to  the p-azophenylarsonate  group 
(anti-Ar  I antibodies) some of which share a cross-reactive idiotype (CRI) (7) and that the 
appearance  of this  idiotype  can  be  suppressed  by  prior  inoculation  of rabbit  anti- 
idiotypic antibodies  (8).  Suppressed  mice  produce  normal  concentrations  of anti-Ar 
antibodies which lack the CRI (9). When spleen cells from suppressed, nonimmune mice 
were  adoptively transferred  to  lethally irradiated recipients, the  latter,  when  immu- 
nized,  produced  anti-Ar  antibodies  lacking  the  CRI.  When  the  recipients  received 
normal spleen cells 17 days after the adoptive transfer of suppressed cells the anti-Ar 
antibodies formed upon subsequent immunization possessed the idiotype (6). If, however, 
the animals were challenged with antigen on day 7,  between the adoptive transfers of 
suppressed  and  normal  cells,  the  anti-Ar antibodies  formed  when  the  animals  were 
immunized lacked detectable amounts  of the  CRI.  This suggested the possibility that 
the lymphocytes transferred from a  suppressed animal, when brought into contact with 
antigen,  generated  memory  B  cells  incapable  of  producing  the  CRI,  which  were 
selectively triggered by antigen and prevented the expression of idiotype by the normal 
cells  that  were  transferred  on  day  17.  An  alternative  interpretation  was  that  the 
injection of antigen on day 7 very rapidly generated the production of idiotype-specific 
suppressor T  cells, shown by Eichmann  (3)  to be produced,  after a  prolonged waiting 
period, by mice inoculated with anti-idiotypic antibodies. 
Subsequent experiments of Ward et al.  2 demonstrated the possibility of suppressing 
the appearance of the CRI by adoptive transfer of B  cells, from idiotypically suppressed 
hyperimmunized  A/J  mice  that  were  producing anti-Ar antibodies lacking CRI,  into 
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mildly irradiated (200 rads) A/J recipients. Transfers of limiting dilutions of separated 
populations of B and T cells indicated that, on a numerical basis, B cells were at least as 
effective  as  T  cells  in  transferring  the  suppression,  and  that  suppression  could  be 
induced by B-cell populations containing far fewer T cells, as contaminants, than were 
required to induce the suppressed state. Thus, both sets of experiments are consistent in 
suggesting that memory B  cells, possessing receptors that recognize the p-azophenylar- 
sonate  group  but  lack the  CRI,  can  compete  effectively for  antigen  and  prevent  the 
expression of the idiotype in recipient animals that would otherwise have produced it. 
Because  it is impossible to rule  out the presence of a  small percentage  of T 
cells in  enriched  B-cell populations,  the  possibility existed that  the  virtually 
complete  suppression  of  CRI,  as  a  consequence  of  B-cell  dominance,  might 
require  the  synergistic  action  of a  small  number  of suppressor  T  cells.  The 
experiments  reported  here  were  designed  to  test  for  suppression  of idiotype 
under  circumstances  in  which  idiotype-specific  suppressor  T  cells  were  not 
likely to be present. The protocol consisted in immunizing  BALB/c mice, which 
are CRI-negative, against the Ar hapten  group, and transferring  their immune 
spleen cells into mildly irradiated  C.AL-20 mice; the latter possess the allotype 
of  the  AL/N  strain  on  a  BALB/c  genetic  background  and  are  capable  of 
producing the  CRI.  This procedure  resulted  in essentially complete inhibition 
of the synthesis of the CRI upon subsequent  immunization,  as determined  by a 
sensitive  assay.  The  inhibitory  cells were  insensitive  to  treatment  with  anti- 
Thy-l.2 and complement.  Other experiments  were carried out to exclude a  role 
for (hypothetical) helper T  cells specific for idiotypes other than  the  CRI or for 
carrier-specific  suppressor  T  cells.  Implications  with  respect  to  the  role  of 
clonal dominance  in the immune  response will be discussed. 
Materials  and  Methods 
BALB/c mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. The mice were 
8-14 wk of age at the start of each experiment. Mice of the congenic C.AL-20 strain, which have 
genes controlling the CH-region allotype of the AL/N strain on a BALB/c background, were the 
gift of Dr. Michael Potter, National Institutes of Health. Rabbits were obtained from the White 
Pine  Rabbitry,  East  Douglas,  Mass.  Keyhole limpet hemocyanin  (KLH)  was  obtained from 
Calbiochem,  La  Jolla,  Calif.  p-aminophenylarsonic  acid,  obtained  from  Eastman  Organic 
Chemicals Div., Eastman Kodak Co., Rochester,  N.  Y.,  was recrystallized from a  mixture of 
ethanol and water.  Bovine IgG (BGG) and bovine serum albumin (Fraction V) were obtained 
from Sigma Chemical Co.,  St.  Louis, Mo.  Complete and incomplete Freund's adjuvants were 
purchased from the Difco Laboratories, Detroit, Mich., and ascitic fluid containing anti-Thy-l.2 
(AKR anti-C3H) antibodies from Litton Bionetics Co., Kensington, Md. RPMI-1640 medium and 
decomplemented fetal calf serum were obtained from Grand Island Biological Co., Grand Island, 
N.Y. 
The following methods have been described: conjugation of proteins with p-aminophenylarsonic 
acid by diazotization (10); induction in mice of ascitic fluids containing anti-Ar antibodies, using 
KLH-Ar as immunogen (11); specific purification of anti-Ar antibodies, production of rabbit anti- 
idiotypic antibodies against the anti-Ar antibodies of A/J mice, and the radioimmunoassay for 
CRI, using 10 ng of 12~I-labeled specifically purified anti-At antibodies as ligand and goat anti- 
rabbit Fc as the antiglobulin reagent  (7); specific purification of rabbit anti-mouse IgG (12). 
Proteins were iodinated by the method of Hunter, by using chloramine-T (13). Anti-Ar antibodies 
in serum or ascitic fluids were quantitated essentially by the procedure of Klinman et al. (14), 
which employs polyvinyl microtiter plates as the initial adsorbent for bovine serum albumin-Ar. 
The wells are then exposed to unknown samples containing anti-Ar antibodies, followed by 125I- 
labeled, specifically purified rabbit anti-mouse IgG. A  standard curve is constructed by using 
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Single cell  suspensions  were  obtained  by  teasing  spleens  through  stainless  steel  mesh  or 
between two frosted glass plates.  To count lymphocytes, the erythrocytes were first lysed with 
ammonium  chloride solution  (15).  Viability,  as  estimated by trypan  blue exclusion,  exceeded 
85%.  Data  presented  in the tables  refer to numbers  of viable lymphocytes.  Spleen cells were 
transferred adoptively, by the intravenous route, into recipient mice which had received 200 rads 
over a period of  5 min from a ~sTCs  source (J. L. Sheperd and Associates,  Glendale, Calif.).  The 
recipient  mice were immunized by  two inoculations  of  0.25  mg of  KLH-Ar emulsified  in  complete 
Freund's adjuvant (CFA), on days 3 and 10 after  adoptive transfer,  followed  by two additional 
injections  of  the antigen in incomplete Freund's adjuvant on days 17 and 24. Mice were bled 
retro-orbitally  on day 31 and their  sera  tested  for  content of  anti-Ar antibodies  and of  CRI. 
For treatment of cells  with anti-Thy-l.2 reagent,  the complement used was obtained by 
screening sera of 2-pound rabbits  for low cytotoxicity.  The complement-containing serum was 
adsorbed  according to  Boyse (16).  Anti-Thy-l.2 plus  complement killed  a maximum of  55% of  A/J 
splenic  leukocytes and over 90% of  leukocytes not retained  on a nylon  wool column. Nonspecific 
killing  by each reagent  alone was less  than 10%. 
Results 
The  results  in  Table  I  indicate,  first,  that  irradiated  C.AL-20  mice  are 
capable of producing anti-Ar antibodies with the CRI when immunized with 
KLH-Ar.  The  adoptive  transfer  of 10  ×  106  or  50  ×  10  ~ spleen  cells  from 
nonimmune BALB/c mice or from BALB/c mice that had been hyperimmunized 
with KLH (footnote, Table  I)  did not prevent the appearance of the idiotype 
upon subsequent immunization with KLH-Ar. The amounts of anti-Ar antibod- 
ies required for 50% inhibition in the radioimmunoassay for the idiotype were 
comparable  to  those  in  the  controls.  Some  evidence  for  a  reduction  in  the 
concentration of idiotype, per unit weight of anti-Ar antibodies, can be seen in 
the  group  that  received  75  ×  106  cells.  This  may  be  attributable  to  the 
production of anti-Ar antibodies of BALB/c origin in the mice which received 
this larger number of cells, which would lower the proportion of molecules with 
the CRI. 
In contrast, the adoptive transfer of only 10  x  106  cells from BALB/c mice 
that had been immunized with KLH-Ar caused essentially complete suppression 
of the  CRI in the  C.AL-20 recipients.  Since it seems unlikely that BALB/c 
mice,  which are  incapable  of producing the  idiotype  (7,  17), would develop 
idiotype-specific suppressor T cells upon immunization with KLH-Ar, the data 
suggest that the suppression of idiotype was caused by the selective capture of 
antigen by BALB/c B cells with receptors for the p-azophenylarsonate group, 
that were present in the hyperimmunized donors. The average anti-Ar titers 
for groups 1 and 4 in Table I were 0.8 and 0.4 mg/ml, respectively. 
Further evidence that the inhibition indicated by the data in Table I is not 
attributable to suppressor T cells was obtained by treating cells from the donor 
mice in vitro with anti-Thy-l.2 and complement before the transfer (Table II). 
In these experiments the cells remaining after treatment of 20  x  l0  s splenic 
lymphocytes, from BALB/c mice immunized with KLH-Ar, were transferred 
into  each  recipient;  51%  of the  cells  were  killed.  The  remaining  cells  still 
caused essentially complete suppression of the idiotype upon subsequent im- 
munization of the C.AL-20 recipients. 
To  investigate the  persistence  of the  suppressed  state  the  last  group  of 
recipients  in  Table  I,  that  had  received  100  ×  l0  s  cells  from BALB/c mice 
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TABLE  l 
Inhibition of CRI in C.AL-20 Mice by Transfer of Spleen Cells from BALB/c Mice 
Immunized with KLH-Ar* 
Donor of  cells  transferred 
No. of  cells 
No. of  recipi-  transferred  to 
ent mice 
each mouse 
Nanograms anti-Ar Ab re- 
quired for 50% inhibition* 
× 10 -e 
None§  19  None 
Nonimmune BALB/c 
41JI 44,  45,  48,  90,  93,  94, 
110, 200, 280, 430, 520, 560, 
570,580,730, 750,800,1,200 
5  10  38, 56, 96,  140, 190 
5  50  39, 45, 140, 150, 190 
5  75  110, 320, 500, 500, 2,000 
BALB/c  immunized  4  10  49, 56, 86,  110 
with KLH¶  3  50  41, 150, 260 
4  75  70, 130, 530, 4,800 
BALB/c  immunized  5  i0  >13,000 to >25,000 
with KLH-Ar¶  4  50  >24,000 to >29,000 
10  100  >9,000 to >15,000 
* All  C.AL-20 mice  received  200  rads,  4  h before  the  adoptive  transfer.  They were then  immunized 
by  four  i.p.  inoculations  of  0.25  mg of  KLH-Ar in  CFA over  a 24  day  period  and  bled I  wk later. 
* 10 ng of  labeled  ligand were used in the radioimmunoassay. 
§ C.AL-20 mice were irradiated  (200  rads)  and immunized (without receiving  cells). 
[]  Each value represents  an individual  mouse. 
¶ A single pool  of  donor  cells  was used.  Donors  had been  immunized by  4 weekly i.p.  inoculations 
of  0.25 mg of  antigen  in  complete Freund's  adjuvant (volume ratio  of  antigen  to  adjuvant, 1:1). 
Adoptive transfers  were carried  out 2 wk after  the last  injection. 
TABLE  II 
Effect of Treatment with Anti-Thy-1.2 and Complement on the 
Capacity of Spleen Cells from BALB/c Mice Immunized with 
KLH-Ar to Suppress CRI in C,4L-20 Recipients* 
Treatment with  Number of 
anti-Thy-l.2  plus  C.AL-20 recip-  Nanograms anti-Ar Ab re- 
complement  ients  quired for  50% inhibition* 
(-)  7  >4,000 to >6,500 
(+)  5  >3,500 to >11,500 
* Each recipient mouse received 200 rads and 20 x  10  e splenic lympho- 
cytes, or the cells remaining after treatment of 20  x  106 lymphocytes 
with  anti-Thy-l.2  and  C;  the treatment  killed 51%  of the  cells.  A 
single pool of 300  x  108 cells was used;  100  x  10  e cells were treated 
and aliquots injected into recipient mice. The immunization procedure 
is described in footnote*,  Table I. 
* 10 ng of labeled ligand was used in the radioimmunoassay. 
were injected i.p. with 0.25 mg of KLH-Ar in CFA and bled i  wk later. Anti-Ar 
titers  ranged  from  0.3  to  1.5  mg/ml.  25  ~l  of serum  from  each  of the  mice 
caused  less  than  30%  inhibition  of binding  of 10  ng  of labeled  ligand  in  the 
radioimmunoassay  for CRI. 1578  B-CELL  DOMINANCE 
Two  additional  hypotheses  involving T  cells  were  considered  that  might 
account for the data. These hypotheses, which are considered in detail in the 
Discussion, involve a  role for BALB/c idiotype-specific helper T cells or KLH- 
specific suppressor T cells, which might have been present in small numbers in 
the spleen cells treated with the anti-Thy-l.2 reagent and complement. 
An experiment was performed in which it was believed that neither of these 
mechanisms would be operative. The BALB/c donors were primed with BGG- 
Ar,  rather than KLH-Ar, and the  C.AL-20 recipients were  immunized with 
KLH-Ar after the adoptive transfer. Under these circumstances one would not 
expect to generate idiotype-specific helper T cells with specificity for KLH, and 
carrier-specific suppressor T cells should not be relevant. This would, however, 
stimulate B cells in the BALB/c donors with anti-Ar receptors lacking CRI. If 
B-cell competition is responsible for the inhibition, the cells from such donor 
mice would be expected to cause inhibition of the production of CRI. The data 
in Table III indicate that cells from such donors were highly inhibitory when 
10  ×  106  cells  or  more  were  transferred;  I  x  106  cells  did  not  prevent  the 
synthesis of the CRI. 
The  transfer  of  10  ×  106  or  50  ×  106  lymphocytes  from  BALB/c  mice 
immunized with unconjugated BGG also caused some depression of the concen- 
tration of CRI in the anti-Ar antibodies subsequently induced in the C.AL-20 
recipients. The results are similar to those obtained with 75  ×  106 cells from 
nonimmune donors or donors immunized with KLH (Table I). Since the spleen 
cells transferred undoubtedly contained unprimed B  cells with specificity for 
the Ar hapten group,  these results may be  attributable to the production of 
anti-Ar antibodies of BALB/c origin in the recipient mice. As already indicated, 
this would lower the relative proportion of anti-Ar antibodies with the CRI. 
The reduction was,  however, far smaller than that induced by BALB/c cells 
primed with the Ar hapten group. 
The  average concentration of the  CRI in group  1,  Table  III,  in which the 
mice were irradiated but did not receive cells, is higher than that of group 1 in 
Table I, in which the mice were similarly treated. The explanation for this is 
not apparent but may be attributable to the small size of the group.  In both 
instances, however, the transfer of cells from BALB/c mice immuriized against 
the Ar hapten group caused almost complete suppression of the idiotype. 
An  additional  set  of experiments  was  carried  out  in  which  the  splenic 
lymphocytes from BALB/c mice immunized with BGG-Ar were treated with 
anti-Thy-l.2 and complement before transfer to  C.AL-20 recipients that had 
received  200  rads.  The  transfer  of cells  remaining after  treating  20  ×  106 
BALB/c splenic lymphocytes caused complete inhibition of synthesis of the CRI 
in  three  of the  four  recipients  and  more  than  90%  inhibition in  the  other 
recipient, upon subsequent immunization with KLH-Ar (data not shown). 
Discussion 
The data presented indicate that the adoptive transfer of B cells, primed to a 
hapten but incapable of producing a  specific idiotype, can inhibit completely 
the  appearance  of the  idiotype  that  would  otherwise  have  appeared  upon 
immunization of the recipient animal with the same hapten group. The donors BLAIR  M.  EIG,  SHYR-TE  JU,  AND  ALFRED  NISONOFF  1579 
TABLZ III 
Inhibition of CR1 in C.AL-20 Mice by Adoptive Transfer of Spleen  Cells 
from BALB/c Mice Immunized with BGG-Ar* 
No. of  cells  Nanograms anti-Ar Ab 
Donor of  cells  trans-  No. of  re-  tranferred to  required for 50% inhi- 
ferred  cipient  mice  each mouse  bition$ 
×  10 -e 
None§  5  None  30,11 30, 40, 40, 60 
BALB/c immunized  3  10  150,  470, 850 
with BGG¶  3  50  31, 110, 690 
2  75  600, 2,000 
BALB/c immunized 
with BGG-Ar~ 
5  1  20, 60, 80, 100,  120 
1  10  1,500 
4  10  >5,000 to >13,000 
1  50  6,600 
4  50  >7,000 to >35,000 
3  75  >4,500 to >8,500 
Footnotes as in Table I. 
in  these  experiments  were  BALB/c  and  the  recipients  were  C.AL-20  mice 
irradiated  with  200  rads.  C.AL-20  mice,  which  possess genes  coding for the 
immunoglobulin  heavy chains  of the  AL/N strain  on a  BALB/c background, 
produce anti-Ar antibodies with an idiotype (CRI) characteristic of the A strain, 
whereas the  anti-Ar  antibodies  of BALB/c mice do not express this  idiotype 
(7,  17-19). In nearly all recipient mice that received 10  ×  10  ~ cells or more the 
CRI was undetectable by a  highly sensitive radioimmunoassay. 
The  adoptive  transfer  of  specific  idiotypes  or  spectrotypes  is  not  novel, 
having  previously been  demonstrated  in  several laboratories  (e.g.,  1-5).  The 
unexpected finding was the essentially complete suppression of the CRI.  It is 
difficult to decide whether this can be explained simply by statistical consider- 
ations or whether some type of active suppression is involved. Suppression by 
idiotype-specific T cells seems, however, to be ruled out.  First, the transferred 
cell  populations  were  treated  with  anti-Thy-l.2  and  complement.  A  second 
factor is that the donor mice were BALB/c whereas the recipients were C.AL- 
20 mice. Since BALB/c mice do not produce the CRI one would not expect them 
to synthesize idiotype-specific suppressor T cells. In addition,  previous demon- 
strations of the production of idiotype-specific suppressor T cells have required 
the initial  use of anti-idiotypic antibodies  (3,  20),  which were not employed in 
the present work. 
In  the  first  set  of experiments,  the  BALB/c donors  were  immunized  with 
KLH-Ar  before  the  adoptive  transfer;  the  C.AL-20  recipients,  subsequently 
immunized  with  KLH-Ar,  failed to  produce the  idiotype.  It  was  conceivable 
that  primed  BALB/c donor mice generated  helper T  cells with  specificity for 
idiotypes  other  than  the  CRI  characteristic  of anti-At  antibodies  of the  A 
strain.  (This assumes the existence of idiotype-specific helper cells.) It would 
have to be argued,  in addition,  that  the treatment  with anti-Thy-l.2  did not 
completely eliminate  such helper T  cells.  Another  possibility considered was 1580  B-CELL  DOMINANCE 
that the BALB/c donors which were primed with either KLH or KLH-Ar gen- 
erated carrier-specific suppressor T  cells which interfered with the activity of 
KLH-specific helper T  cells in the C.AL-20 recipients.  If the production of the 
CRI requires more "help" from T  cells than the production of other idiotypes 
in the C.AL-20 strain,  this might have selectively depressed the proportion of 
antibody molecules bearing the  CRI.  Again,  the results  obtained after treat- 
ment with anti-Thy-l.2 and complement would argue against this mechanism. 
Nevertheless,  in  an  effort to rule  out these possibilities  additional  experi- 
ments were performed in which the BALB/c donors were primed with BGG-Ar 
rather  than  KLH-Ar and  the  C.AL-20  recipients  were then  immunized  with 
KLH-Ar. This was done to obviate possible effects of KLH-specific T cells from 
the BALB/c donors. The results indicated that spleen cells from BALB/c donors 
immunized with BGG-Ar were capable of completely inhibiting the appearance 
of the  CRI  in  C.AL-20  recipients  subsequently  immunized  with  KLH-Ar.  In 
addition,  the suppressive activity was insensitive to treatment  with anti-Thy- 
1.2 and complement. The data appear to exclude a role for KLH-specific T cells. 
Included among the control experiments were the adoptive transfers of cells 
from nonimmunized  BALB/c mice or from BALB/c mice that had been immu- 
nized with unconjugated KLH or BGG. In each instance the C.AL-20 recipients 
produced  substantial  concentrations  of anti-Ar  antibodies  bearing  the  CRI, 
indicating  that  graft-vs.-host  reactions  were not responsible  for inhibition  of 
idiotype synthesis. These experiments showed, in addition, that preimmuniza- 
tion of the donor mice to the hapten group was essential for marked suppression 
of the CRI in the C.AL-20 recipients.  The results of these control experiments 
are consistent with the concept that inhibition is caused by B-cell dominance. 
A  number  of factors  are  relevant  to  the  complex  question  as  to  whether 
numerical superiority of B cells with specificity for anti-Ar antibodies lacking 
the CRI is solely responsible for the observed effect. Klinman  has shown that 
the  number  of B  cells  specific  for  hapten  increases  less  than  10-fold  upon 
immunization  (21).  However, his immunization  schedule was considerably less 
rigorous than ours.  It is possible, therefore,  that the number of memory cells 
may  have  been  increased  to  a  greater  extent  in  our  donor  animals.  If one 
assumes a  B-cell precursor frequency for the  CRI of 1 in  10,000,  a  relatively 
high value  (22),  then a  normal recipient mouse would possess only -10,000 B 
cells  with  receptors  for  the  CRI.  In  addition,  this  number  may  have  been 
reduced considerably as a result of irradiation with 200 R. It is thus difficult to 
assess  the  ratio  of the  two  types of relevant  B  cells  in  the  recipients,  i.e., 
primary  B  cells with  receptors  for  CRI and  primed  donor  cells  with  anti-Ar 
receptors lacking the idiotype. 
A  factor that is probably more significant  is the greater avidity of memory 
cells for antigen.  A  number of investigators have shown that primed cells are 
much  more  easily  triggered  than  unprimed  cells  by antigen  and  that  this 
reflects a higher avidity of such cells for antigen and/or an increased number of 
receptors  (23-31);  actually,  the  two factors  may be interrelated  since  a  high 
density of receptors would increase the possibility of multivalent attachment of 
the antigen.  It was nevertheless surprising that the idiotype was not detectable 
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the  Ar  hapten  group.  Perhaps  the  simplest  hypothesis  is  that  the  very low 
concentration of CRI was due to a  combination of numerical superiority of the 
donor cells lacking the  CRI and their  greater ease of triggering.  Once estab- 
lished, the ratio of anti-Ar antibodies with and without the CRI might tend to 
be  quite  stable.  This  possibility  is  supported  by  the  prolonged  persistence 
during  immunization  of antibodies of a  given molecular species (e.g.,  32-36), 
although  gradual  changes  are seen.  In this context it is relevant that  in the 
present experiments  the suppressed state persisted for at least 6 mo in those 
mice which were tested. 
The high  sensitivity of the assay for idiotype indicates that the presence of 
secondary B cells can prevent essentially completely the expression of primary 
cells  with  receptors  of the  same  specificity  but  of a  different  idiotype.  A 
corollary conclusion  is that  clones of cells  initially  triggered  in  the  immune 
response  may tend  to  dominate  the  response  for  long  periods  of time.  It  is 
necessary, however, to consider the fact that the affinity of antibodies tends to 
increase during the course of the immune response (37-39). One might reconcile 
such  findings  with  the  present  results  on  the  basis  that:  (a)  the  type  of 
inhibition we have observed would apply to antibodies of relatively low affinity; 
it has been found that anti-Ar antibodies bearing the CRI are somewhat lower 
in  average  affinity than  the  remainder  of the  anti-Ar  population  in the  A/J 
strain  (40).  It would be relevant to determine whether the transfer of BALB/c 
B  cells resulted in complete inhibition  of the  C.AL-20 anti-Ar  response.  This 
would be difficult to do with the system used here because BALB/c and C.AL- 
20 mice do not differ with respect to IgG1 allotype, and most anti-Ar antibodies 
of the  A  strain  belong  to  this  subclass  (41).  (b)  The  frequently  reported 
increase in average affinity may reflect the preferential expansion of secondary 
clones of cells that were triggered by the initial antigenic stimulation;  in our 
experiments  secondary  B  cells  were  adoptively  transferred  into  unprimed 
animals.  In  any  event,  the  virtually  complete  suppression  of  an  idiotype 
through B-cell dominance was rather unexpected and the possibility of B-cell- 
mediated  suppression  through  an  unknown,  active  mechanism  cannot  be 
excluded. 
In the absence of direct evidence for active suppression one might postulate 
that  the  precursor  cells  committed  to  the  CRI  persisted  in  a  dormant  state 
throughout  the period of the  experiments.  In  the case of suppression with T 
cells or antiidiotypic antibodies such cells may be eliminated.  A question under 
investigation  is whether  idiotype-specific suppressor T  cells  are  generated  in 
mice  that  have  been  suppressed  initially  by the  transfer  of hyperimmune  B 
cells lacking receptors with the CRI. 
Summary 
Mice of the C.AL-20 strain, which express genes controlling CH regions of the 
AL/N strain  on a  BALB/c background,  normally synthesize antibodies to the 
p-azophenylarsonate group (anti-Ar antibodies) with an idiotype characteristic 
of the  A  strain.  The  synthesis  of the  idiotype,  as quantitated  by a  sensitive 
assay, can be completely inhibited by the transfer of leukocytes from BALB/c 
mice  producing  anti-Ar  antibodies,  which  lack  the  idiotype.  A  number  of 1582  B-CELL  DOMINANCE 
control experiments show that the inhibition  is not attributable  to suppressor 
T  cells and that the synergistic action of such cells is not required.  The results 
indicate  that  B-cell  dominance,  mediated  by secondary  cells,  can  completely 
prevent the expression of unprimed cells with receptors of the same specificity. 
It is uncertain whether this effect is due entirely to selective capture of antigen 
by the secondary cells, or whether some type of active suppression by B  cells is 
involved. 
Received for publication 19 August 1977. 
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